GOSIA GENOMICS
Live / Allowed — Approved for publication (as of 07 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99520613
- Mark type
- Word mark
- Filed
- 28 Nov 2025
Goods and services
- Class 035 — Advertising and business services: Online retail store services featuring DNA collection kits and health and wellness analysis services
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring non-downloadable software using artificial intelligence (AI) specifically focused on women's health and general health and wellness, namely, software for performing diagnosis and predisposition risk assessment, which includes the analysis, interpretation, reporting, and provision of personalized recommendations based on genomic data, and also includes patient monitoring, and the provision of a knowledge portal and access to laboratory test results; Scientific research in the fields of women's health, general wellness, genomics, and artificial intelligence (AI)
- Class 044 — Medical, beauty and agricultural services: (Based on Use) Genetic testing for medical purposes, namely, genomic testing and analyses services for wellness, diagnostic, and predisposition testing specifically focused on women's health, including gynecological and menstrual health, reproductive health, fertility, menopause, maternal and pregnancy health, skin care, diet, sleep, and fitness; Genetic testing for medical purposes, namely, general genomic testing and analyses services for wellness, diagnostic, longevity, and predisposition testing for gut health, nutrition, diet, weight loss, food intolerance, fitness, skin care, dermatology, medical aesthetics, pharmacogenomics, and cognitive health; (Based on Intent to Use) Nutrition counseling services with a specific focus on women's health, including gynecological, menstrual, reproductive, peri-menopause, menopause, post-menopause, maternal, and pregnancy health; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories, including hormone level testing services
Owner
- Gosia Genomics Inc, Kearny, NJ, US
Prosecution history
- 07 Oct 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Oct 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Oct 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Oct 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 07 Oct 2026 — EXAMINER'S AMENDMENT ENTERED
- 07 Oct 2026 — EXAMINERS AMENDMENT E-MAILED
- 07 Oct 2026 — EXAMINERS AMENDMENT -WRITTEN
- 12 Jul 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 12 Jul 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 13 Apr 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Apr 2026 — NON-FINAL ACTION E-MAILED
- 13 Apr 2026 — NON-FINAL ACTION WRITTEN
- 01 Apr 2026 — ASSIGNED TO EXAMINER
- 26 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED